Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR (2015) Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 131:495–502

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, Müller-Hülsbeck S, Nehler MR, Benenati JF, Scheinert D (2015) Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 373:145–153

Article  CAS  PubMed  Google Scholar 

Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U (2008) Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358:689–699

Article  CAS  PubMed  Google Scholar 

Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Ströbel A, Schult I, Scheinert D (2018) 12-Month results from the first-in-human randomized study of the ranger paclitaxel-coated balloon for femoropopliteal treatment. JACC Cardiovasc Interv 11:934–941

Article  PubMed  Google Scholar 

Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H (2018) Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan randomized trial. J Endovasc Ther 25:109–117

Article  PubMed  Google Scholar 

Shimada T, Shima Y, Takahashi K, Miura K, Takamatsu M, Ikuta A, Habara S, Tanaka H, Goto T, Izumiya Y, Kadota K (2022) Delayed stenosis regression after drug-coated balloon angioplasty for femoropopliteal artery lesions. Heart Vessels 37:730–737

Article  PubMed  Google Scholar 

Katsanos K, Spiliopoulos S, Paraskevopoulos I, Diamantopoulos A, Karnabatidis D (2016) Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability. J Endovasc Ther 23:356–370

Article  PubMed  Google Scholar 

Gongora CA, Shibuya M, Wessler JD, McGregor J, Tellez A, Cheng Y, Conditt GB, Kaluza GL, Granada JF (2015) Impact of paclitaxel dose on tissue pharmacokinetics and vascular healing: a comparative drug-coated balloon study in the familial hypercholesterolemic swine model of superficial femoral in-stent restenosis. JACC Cardiovasc Interv 8:1115–1123

Article  PubMed  Google Scholar 

Cassese S, Ndrepepa G, Fusaro M, Kufner S, Xhepa E (2019) Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials. EuroIntervention 15:e560–e562

Article  PubMed  Google Scholar 

Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, Schröder H, Euringer W, Ulrich M, Brechtel K, Brucks S, Blessing E, Schuster J, Langhoff R, Schellong S, Weiss N, Scheinert D (2020) COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions. Eur Heart J 41:2541–2552

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liistro F, Weinberg I, Almonacid Popma A, Shishehbor MH, Deckers S, Micari A (2022) Paclitaxel-coated balloons versus percutaneous transluminal angioplasty for infrapopliteal chronic total occlusions: the IN.PACT BTK randomised trial. EuroIntervention 17:e1445–e1454

Article  PubMed  PubMed Central  Google Scholar 

Boitet A, Grassin-Delyle S, Louedec L, Dupont S, Lamy E, Coggia M, Michel JB, Coscas R (2019) An experimental study of paclitaxel embolisation during drug coated balloon angioplasty. Eur J Vasc Endovasc Surg 57:578–586

Article  PubMed  Google Scholar 

Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K, Investigators P (2023) Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc 12:e025677

Article  PubMed  Google Scholar 

Kleber FX, Schulz A, Waliszewski M, Hauschild T, Böhm M, Dietz U, Cremers B, Scheller B, Clever YP (2015) Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty. Clin Res Cardiol 104:217–225

Article  CAS  PubMed  Google Scholar 

Scheller B, Fischer D, Clever YP, Kleber FX, Speck U, Böhm M, Cremers B (2013) Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months. Clin Res Cardiol 102:469–472

Article  PubMed  Google Scholar 

Shimada T, Habara S, Tanaka H, Kadota K (2021) Plaque volume reduction after drug-coated balloon angioplasty for superficial femoral artery lesion. Cardiovasc Interv Ther 36:263–265

Article  PubMed  Google Scholar 

Kobayashi N, Hirano K, Yamawaki M, Araki M, Sakai T, Sakamoto Y, Mori S, Tsutsumi M, Nauchi M, Sahara N, Honda Y, Makino K, Shirai S, Mizusawa M, Sugizaki Y, Nakano T, Fukagawa T, Kishida T, Kozai Y, Setonaga Y, Goda S, Ito Y (2020) Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: follow-up intravascular imaging. SAGE Open Med Case Rep. 8:2050313X20907825

PubMed  PubMed Central  Google Scholar 

Hayakawa N, Kodera S, Arakawa M, Hirano S, Shakya S, Kanda J (2022) Clinical outcome of drug-coated balloon versus scaffold device in patients with superficial femoral artery chronic total occlusion. Heart Vessels 37:282–290

Article  PubMed  Google Scholar